SecBot SecBot
SECBOTREPLAY Home › Report › DYN

DYN · Atlas Venture Fund XI, L.P

Dyne Therapeutics, Inc. · 144 filed Jun 29, 2026 at 17:50 ET

At the news

BEARISHIMPACT 4/10

144 filed Jun 29, 2026 at 17:50 ET

Atlas Venture Fund XI, L.P. and Atlas Venture Opportunity Fund I, L.P., two affiliated venture capital funds, filed Form 144 notices on June 29, 2026, indicating intent to sell a combined 102,969 shares of Dyne Therapeutics (DYN) valued at approximately $2.16 million. As early investors, these sales represent a partial exit by a major insider, though the dollar amount is modest relative to DYN's $3.5B market cap.

  • Atlas Venture Fund XI, L.P. files Form 144 to sell 102,969 shares of DYN common stock.
  • Atlas Venture Opportunity Fund I, L.P. also files a Form 144 on the same date (share count not specified in available text).
  • Total proposed sale value is approximately $2,156,170.86 based on the first filing.
  • Shares were acquired in a private placement on July 31, 2020.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access